Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Terazosin for Dementia With Lewy Bodies [Phase 1, Phase 2]

View source ↗

Summary

The update reports a Phase 1/Phase 2 study of terazosin for dementia with Lewy bodies that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terazosin (terazosin)

Snippet

Sponsor: Qiang Zhang | Conditions: Dementia With Lewy Bodies | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING